Home > Medical > Asthma > Manage your asthma advertorial Updated 12 September 2016 Asthma control in children now more affordable Pharma Dynamics, South Africa’s leading supplier of cardiovascular medicine is pleased to announce the launch of SINTAIR tablets, effective therapy for asthma in children aged 2 years and older. 0 Image from Pharma Dynamics ~ Celebrities with asthma Adorable, asthmatic otter learns to use inhaler SINTAIR (montelukast sodium equivalent to montelukast), is now available in cherry flavoured 4 mg and 5 mg chewable tablets, as well as 10 mg tablets for patients 15 years and older. Once daily SINTAIR has been registered for the prophylaxis and chronic treatment of atopic asthma, and offers a valuable treatment option to younger patients who may have difficulty using inhalers, causing dose delivery and associated outcomes to be variable. SINTAIR tablets are effective therapy for asthma in children aged 2 years and older. Similarly, in adolescents and adults, SINTAIR improves multiple parameters of asthma control and is considered to be a useful additional in the step-up approach, or combination therapy, for moderate and severe persistent asthma not controlled with inhaled corticosteroids.SINTAIR is now available to your patients at up to 47 % less than the originator montelukast. (1)SINTAIR is available in 3 dosage strengths: SINTAIR 4mg, Montelukast sodium equivalent to 4mg montelukast, 30 chewable tablets, R150.00SINTAIR 5mg, Montelukast sodium equivalent to 5mg montelukast, 30 chewable tablets, R150.00SINTAIR 10mg, Montelukast sodium equivalent to 10mg montelukast, 30 tablets, R150.00The package insert as approved by the Medicines Control Council is available upon request from Karin Bissolati at (021) 707 7000 or email email@example.comMarc WilenskyGroup Product Manager(021) 707 7000S3 Sintair 4 mg. Each tablet contains montelukast sodium equivalent to 4 mg montelukast. Reg. No. 44/10.2.2/0829S3 Sintair 5 mg. Each tablet contains montelukast sodium equivalent to 5 mg montelukast. Reg. No. 44/10.2.2/0830S3 Sintair 10 mg. Each tablet contains montelukast sodium equivalent to 10 mg montelukast. Reg. No. 44/10.2.2/0831For full prescribing information, refer to the package insert approved by the Medicines Regulatory Authority.Reference:(1) The Department of Health website. http://www.doh.gov.za – Accessed 10/05/2013. NEXT ON HEALTH24X Most teens who abuse ADHD meds get them from others 2016-03-30 13:52 More: AsthmaManage your asthma advertisement From our sponsors The evolution of asthma treatment How to avoid chronic lung diseases Join us on Facebook What is ACOS and how is it treated?